Corporate Finance

The AI platform transforming insurance brokerages has raised a major Series A to accelerate its mission of automating complex, manual industry workflows.

Dr. Jonathan Gavras, a seasoned executive with deep ties to Healthmap, takes the clinical helm in a strategic move to innovate kidney population health.

A plan to turn a vacant RI hospital into veteran and affordable housing advances, but the developer's financial standing raises questions about the project's path.

A new partnership aims to end fragmented employee benefits, offering a single, unified platform to support working families through complex care needs.

The Virginia-based startup landed a major funding round to automate liquid biopsy sample prep, aiming to make cancer detection faster and more reliable.

Merging onto Nasdaq, RTB Digital's 'Roundtable' platform aims to protect creators and upend the $200B media market with a bold 'Web4' vision.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

Alibaba's earnings reveal a stark divide: soaring AI and cloud growth funded by a strategy that erased quarterly profits and torched cash flow.

Using subatomic particles from deep space, Power Metallic aims to unlock a new frontier of mineral wealth deep beneath its Quebec polymetallic project.

JBS posts a $221M profit despite a major loss in its US beef unit, showcasing the power of its diversified global strategy in volatile markets.

The Fortune 250 retailer's 10% dividend hike reflects strong financials and a strategic navigation of a complex, evolving automotive landscape.

As top execs head to the Morgan Stanley Luxury Conference, investors eye ELC's plans for global growth, profit recovery, and navigating a new era of beauty.

The 2026 Giants of Multiple Sclerosis® awards celebrate the multidisciplinary teams shaping the future of MS, from research to rehabilitation.

Despite a Q3 net loss from market volatility and one-off costs, the energy firm declared its 51st straight dividend, banking on new acquisitions for growth.

Strong Q1 results driven by Australian operations and a record gas compression backlog, offsetting a cautious North American drilling market.

South Jersey Industries offers to buy back $287.5M in notes for just 9 cents on the dollar, forcing a tough choice on bondholders. What's behind the move?

The industrial giant affirms its quarterly payout, a sign of stability for investors as it navigates a costly green transition and recent regulatory hurdles.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

With cash to last into 2027, Bolt Biotherapeutics focuses all hope on its lead cancer drug, BDC-4182, ahead of crucial Q3 clinical data.

AWE 2026 honors XR legends, unveils groundbreaking art and research, and champions a future where spatial AI empowers, not replaces, humanity.